Meyka Pro banner
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH) Stock Overview

Explore Zimmer Biomet Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ZBHNYSE
HealthcareMedical - Devices
$99.57
$1.68(1.72%)
U.S. Market opens in 3h 2m

Zimmer Biomet Holdings, Inc. (ZBH)

Meyka AI Score

Z

Key Financials

Market Cap19.3B
P/E Ratio23.98
EPS (TTM)$8.48
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$110.12
3 Months$91.86
1 Year Target$80.65

ZBH Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Zimmer Biomet Holdings, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ZBH on the NYSE shows an RSI of 63.76, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $80.65 for the NYSE listing.

Key metrics behind Zimmer Biomet Holdings, Inc.'s NYSE-traded stock include a P/E ratio of 23.98 and a market capitalization of 19.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZBH on the NYSE.

Price Performance (NYSE: ZBH)

1-Day Change
1.72%
5-Day Change
3.10%
1-Month Change
5.84%
3-Month Change
20.37%
6-Month Change
3.23%
Year-to-Date (YTD) Change
10.73%
1-Year Change
-3.54%
3-Year Change
-19.51%
5-Year Change
-29.75%
All-Time (Max) Change
244.89%

Contact Information

574 267 6131
345 East Main Street, Warsaw, IN, 46580

Company Facts

170,000 Employees
IPO DateJul 25, 2001
CountryUS
Actively Trading

Frequently Asked Questions